{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:42:17Z","timestamp":1791819737972,"version":"4.3.4"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:00:00Z","timestamp":1728086400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Evidence regarding schizophrenia relapse following acute electroconvulsive therapy (ECT) is sparse compared with that for depression, and we have no clear consensus on relapse proportions. We aimed to provide longitudinal information on schizophrenia relapse following acute ECT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis included randomised controlled trials (RCTs) and observational studies on post-acute ECT relapse and rehospitalization for schizophrenia and related disorders. For the primary outcome, we calculated the post-acute ECT pooled relapse estimates at each timepoint (3, 6, 12, and 24 months post-acute ECT) using a random effects model. For subgroup analyses, we investigated post-acute ECT relapse proportions by the type of maintenance therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Results<\/jats:title>\n                    <jats:p>Among a total of 6413 records, 29 studies (3876 patients) met our inclusion criteria. The risk of bias was consistently low for all included RCTs (4 studies), although it ranged from low to high for observational studies (25 studies). Pooled estimates of relapse proportions among patients with schizophrenia responding to acute ECT were 24% (95% CI: 15-35), 37% (27-47), 41% (34-49), and 55% (40-69) at 3, 6, 12, and 24 months, respectively. When continuation\/maintenance ECT was added to antipsychotics post-acute ECT, the 6-month relapse proportion was 20% (11-32).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Relapse occurred mostly within 6 months post-acute ECT for schizophrenia, particularly within the first 3 months. Relapse proportions plateaued after 6 months, although more than half of all patients could be expected to relapse within 2 years. Further high-quality research is needed to optimise\u00a0post-acute ECT treatment strategies in patients with schizophrenia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/schbul\/sbae169","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T23:18:45Z","timestamp":1726183125000},"source":"Crossref","is-referenced-by-count":9,"title":["Relapse Following Electroconvulsive Therapy for Schizophrenia: A Systematic Review and Meta-analysis"],"prefix":"10.1093","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7741-4151","authenticated-orcid":false,"given":"Nobuatsu","family":"Aoki","sequence":"first","affiliation":[{"name":"Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University , Osaka, 570-8506 ,","place":["Japan"]},{"name":"Discipline of Psychiatry and Mental Health, University of New South Wales , Sydney, NSW, 2031 ,","place":["Australia"]},{"name":"Black Dog Institute , Sydney, NSW, 2031 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3926-8867","authenticated-orcid":false,"given":"Aran","family":"Tajika","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine\/School of Public Health , Kyoto,\u00a0606-8501 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4695-7815","authenticated-orcid":false,"given":"Taro","family":"Suwa","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Kyoto University Graduate School of Medicine , Kyoto,\u00a0606-8507 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2299-3683","authenticated-orcid":false,"given":"Hirotsugu","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Kyoto University Graduate School of Medicine , Kyoto,\u00a0606-8507 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0901-4682","authenticated-orcid":false,"given":"Kazuyuki","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, University of Yamanashi Faculty of Medicine , Yamanashi,\u00a0409-3898 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9178-7172","authenticated-orcid":false,"given":"Toshiyuki","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University , Osaka, 570-8506 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8729-4794","authenticated-orcid":false,"given":"Niina","family":"Uchinuma","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, University of Yamanashi Faculty of Medicine , Yamanashi,\u00a0409-3898 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Tominaga","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Mojimatsugae Hospital , Fukuoka,\u00a0800-0112 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0807-3418","authenticated-orcid":false,"given":"Xiao Wei","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Mood and Anxiety, Institute of Mental Health ,\u00a0 539747 ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azriel H K","family":"Koh","sequence":"additional","affiliation":[{"name":"Department of Mood and Anxiety, Institute of Mental Health ,\u00a0 539747 ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7972-3030","authenticated-orcid":false,"given":"Phern Chern","family":"Tor","sequence":"additional","affiliation":[{"name":"Department of Mood and Anxiety, Institute of Mental Health ,\u00a0 539747 ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4440-9273","authenticated-orcid":false,"given":"Stevan","family":"Nikolin","sequence":"additional","affiliation":[{"name":"Discipline of Psychiatry and Mental Health, University of New South Wales , Sydney, NSW, 2031 ,","place":["Australia"]},{"name":"Black Dog Institute , Sydney, NSW, 2031 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-0390","authenticated-orcid":false,"given":"Donel","family":"Martin","sequence":"additional","affiliation":[{"name":"Discipline of Psychiatry and Mental Health, University of New South Wales , Sydney, NSW, 2031 ,","place":["Australia"]},{"name":"Black Dog Institute , Sydney, NSW, 2031 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6727-7272","authenticated-orcid":false,"given":"Masaki","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University , Osaka, 570-8506 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3267-0554","authenticated-orcid":false,"given":"Colleen","family":"Loo","sequence":"additional","affiliation":[{"name":"Discipline of Psychiatry and Mental Health, University of New South Wales , Sydney, NSW, 2031 ,","place":["Australia"]},{"name":"Black Dog Institute , Sydney, NSW, 2031 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9901-9753","authenticated-orcid":false,"given":"Toshihiko","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University , Osaka, 570-8506 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2159-3776","authenticated-orcid":false,"given":"Toshi A","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine\/School of Public Health , Kyoto,\u00a0606-8501 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2435-4033","authenticated-orcid":false,"given":"Yoshiteru","family":"Takekita","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University , Osaka, 570-8506 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"2026011701172674700_CIT0001","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/acps.13134","article-title":"When to consider electroconvulsive therapy (ECT)","volume":"141","author":"Kellner","year":"2020","journal-title":"Acta Psychiatr Scand."},{"key":"2026011701172674700_CIT0002","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/15622975.2012.696143","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance","volume":"13","author":"Hasan","year":"2012","journal-title":"World J Biol Psychiatry."},{"key":"2026011701172674700_CIT0003","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia","volume":"161","author":"Lehman","year":"2004","journal-title":"Am J Psychiatry."},{"key":"2026011701172674700_CIT0004","volume-title":"Psychosis and Schizophrenia in Adults: Treatment and Management","author":"National Collaborating Centre for Mental Health (UK)","year":"2014"},{"key":"2026011701172674700_CIT0005","first-page":"CD011847","article-title":"Electroconvulsive therapy for treatment-resistant schizophrenia","volume":"3","author":"Sinclair","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"2026011701172674700_CIT0006","first-page":"75","article-title":"Electroconvulsive therapy and schizophrenia: a systematic review","volume":"5","author":"Ali","year":"2019","journal-title":"Mol Neuropsychiatry."},{"key":"2026011701172674700_CIT0007","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/neu.2018.32","article-title":"ECT in schizophrenia: a review of the evidence","volume":"31","author":"Grover","year":"2019","journal-title":"Acta Neuropsychiatr."},{"key":"2026011701172674700_CIT0008","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/15622975.2015.1009163","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia part 3: update 2015 management of special circumstances: depression, Suicidality, substance use disorders and pregnancy and lactation","volume":"16","author":"Hasan","year":"2015","journal-title":"World J Biol Psychiatry."},{"key":"2026011701172674700_CIT0009","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_491_22","article-title":"Clinical practice guidelines for the use of electroconvulsive therapy","volume":"65","author":"Thirthalli","year":"2023","journal-title":"Indian J Psychiatry."},{"key":"2026011701172674700_CIT0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/npr2.12193","article-title":"Japanese Society of Neuropsychopharmacology: \u201cGuideline for Pharmacological Therapy of Schizophrenia\u201d","volume":"41","author":"Japanese Society of Neuropsychopharmacology","year":"2021","journal-title":"Neuropsychopharmacol Rep."},{"key":"2026011701172674700_CIT0011","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/0004867419839139","article-title":"Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of electroconvulsive therapy","volume":"53","author":"Weiss","year":"2019","journal-title":"Aust N Z J Psychiatry."},{"key":"2026011701172674700_CIT0012","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1176\/appi.ajp.2020.177901","article-title":"The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia","volume":"177","author":"Keepers","year":"2020","journal-title":"Am J Psychiatry."},{"key":"2026011701172674700_CIT0013","volume-title":"Electroconvulsive Therapy in Psychiatry","author":"Shen","year":"2009"},{"key":"2026011701172674700_CIT0014","volume-title":"Guidance on the Use of Electroconvulsive Therapy","author":"National Institute for Health and Care Excellence","year":"2009"},{"key":"2026011701172674700_CIT0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/brb3.37","article-title":"Contemporary use and practice of electroconvulsive therapy worldwide","volume":"2","author":"Leiknes","year":"2012","journal-title":"Brain Behav."},{"key":"2026011701172674700_CIT0016","doi-asserted-by":"crossref","DOI":"10.1017\/9781108242028","volume-title":"Handbook of ECT: A Guide to Electroconvulsive Therapy for Practitioners","author":"Kellner","year":"2018"},{"key":"2026011701172674700_CIT0017","volume-title":"The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging (A Task Force Report of the American Psychiatric Association)","author":"American Psychiatric Association","year":"2008"},{"key":"2026011701172674700_CIT0018","doi-asserted-by":"crossref","DOI":"10.1017\/9781911623175","volume-title":"The ECT Handbook","author":"Ferrier","year":"2019"},{"key":"2026011701172674700_CIT0019","first-page":"26","article-title":"Efficacy of electroconvulsive therapy in treatment resistant schizophreinia: a double-blind study","volume":"45","author":"Goswami","year":"2003","journal-title":"Indian J Psychiatry."},{"key":"2026011701172674700_CIT0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.psychres.2018.03.033","article-title":"Maintenance ECT in schizophrenia: a systematic review","volume":"264","author":"Ward","year":"2018","journal-title":"Psychiatry Res."},{"key":"2026011701172674700_CIT0021","first-page":"18","article-title":"Resource utilization and cost in a commercially insured population with schizophrenia","volume":"7","author":"Fitch","year":"2014","journal-title":"Am Health Drug Benefits."},{"key":"2026011701172674700_CIT0022","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1176\/ajp.153.3.321","article-title":"What are the functional consequences of neurocognitive deficits in schizophrenia","volume":"153","author":"Green","year":"1996","journal-title":"Am J Psychiatry."},{"key":"2026011701172674700_CIT0023","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/wps.20516","article-title":"What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia","volume":"17","author":"Correll","year":"2018","journal-title":"World Psychiatry."},{"key":"2026011701172674700_CIT0024","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","article-title":"Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder","volume":"56","author":"Robinson","year":"1999","journal-title":"Arch Gen Psychiatry."},{"key":"2026011701172674700_CIT0025","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00406-019-01055-4","article-title":"What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a \u201creal-world\u201d 2-year follow-up trial","volume":"270","author":"Schennach","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"2026011701172674700_CIT0026","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"2026011701172674700_CIT0027","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12874-017-0391-8","article-title":"Clarifying the distinction between case series and cohort studies in systematic reviews of comparative studies: potential impact on body of evidence and workload","volume":"17","author":"Mathes","year":"2017","journal-title":"BMC Med Res Methodol."},{"key":"2026011701172674700_CIT0028","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00124509-200406000-00005","article-title":"One-year outcome after response to ECT in middle-aged and elderly patients with intractable catatonic schizophrenia","volume":"20","author":"Suzuki","year":"2004","journal-title":"J ECT."},{"key":"2026011701172674700_CIT0029","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1440-1819.2005.01402.x","article-title":"Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia","volume":"59","author":"Suzuki","year":"2005","journal-title":"Psychiatry Clin Neurosci."},{"key":"2026011701172674700_CIT0030","volume-title":"Engauge Digitizer","author":"Mitchell"},{"key":"2026011701172674700_CIT0031","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials."},{"key":"2026011701172674700_CIT0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Health."},{"key":"2026011701172674700_CIT0033","volume-title":"METAN: Stata Module for Fixed and Random Effects Meta-analysis","author":"Fisher","year":"2006"},{"key":"2026011701172674700_CIT0034","first-page":"974","article-title":"Meta-analysis of prevalence","volume":"67","author":"Barendregt","year":"2013","journal-title":"J\u00a0Epidemiol\u00a0Community Health."},{"key":"2026011701172674700_CIT0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1214\/aoms\/1177729756","article-title":"Transformations related to the angular and the square root","volume":"21","author":"Freeman","year":"1950","journal-title":"Ann Math Stat."},{"key":"2026011701172674700_CIT0036","doi-asserted-by":"crossref","first-page":"64","DOI":"10.35566\/jbds\/v3n2\/wang","article-title":"Conducting meta-analyses of proportions in R","volume":"3","author":"Wang","year":"2023","journal-title":"J Behav Data Sci."},{"key":"2026011701172674700_CIT0037","first-page":"138","article-title":"The inverse of the Freeman\u2013Tukey double arcsine transformation","volume":"32","author":"Miller","year":"1978","journal-title":"Am Stat."},{"key":"2026011701172674700_CIT0038","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2288-8-79","article-title":"Undue reliance on I(2) in assessing heterogeneity may mislead","volume":"8","author":"R\u00fccker","year":"2008","journal-title":"BMC Med Res Methodol."},{"key":"2026011701172674700_CIT0039","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jrsm.1230","article-title":"Basics of meta-analysis: I(2) is not an absolute measure of heterogeneity","volume":"8","author":"Borenstein","year":"2017","journal-title":"Res Synth Methods."},{"key":"2026011701172674700_CIT0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12874-021-01381-z","article-title":"Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence","volume":"21","author":"Barker","year":"2021","journal-title":"BMC Med Res Methodol."},{"key":"2026011701172674700_CIT0041","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ."},{"key":"2026011701172674700_CIT0042","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2215-0366(21)00039-0","article-title":"Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies","volume":"8","author":"Kishimoto","year":"2021","journal-title":"Lancet Psychiatry."},{"key":"2026011701172674700_CIT0043","doi-asserted-by":"crossref","first-page":"123","DOI":"10.15171\/ijhpm.2014.71","article-title":"The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence","volume":"3","author":"Munn","year":"2014","journal-title":"Int J Health Policy Manag."},{"key":"2026011701172674700_CIT0044","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int J Evid Based Healthc."},{"key":"2026011701172674700_CIT0045","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00124509-199909000-00002","article-title":"Continuation ECT in treatment-resistant schizophrenia: a controlled study","volume":"15","author":"Chanpattana","year":"1999","journal-title":"J ECT."},{"key":"2026011701172674700_CIT0046","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","volume":"379","author":"Leucht","year":"2012","journal-title":"Lancet (London, England)."},{"key":"2026011701172674700_CIT0047","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/YCT.0b013e3181eee13f","article-title":"Adjunctive psychotropic medications during electroconvulsive therapy in the treatment of depression, mania, and schizophrenia","volume":"26","author":"Haskett","year":"2010","journal-title":"J ECT."},{"key":"2026011701172674700_CIT0048","doi-asserted-by":"crossref","first-page":"21f14325","DOI":"10.4088\/JCP.21f14174","article-title":"Predictors of 6- and 12-month relapse after stopping electroconvulsive therapy: critical considerations, including overfitting in regression and confounding in follow-up studies","volume":"82","author":"Andrade","year":"2021","journal-title":"J Clin Psychiatry."},{"key":"2026011701172674700_CIT0049","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/acps.13352","article-title":"Electroconvulsive therapy: Stayin\u2019 Alive, Stayin\u2019 Well","volume":"144","author":"Kellner","year":"2021","journal-title":"Acta Psychiatr Scand."},{"key":"2026011701172674700_CIT0050","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1038\/npp.2013.149","article-title":"Relapse following successful electroconvulsive therapy for major depression: a meta-analysis","volume":"38","author":"Jelovac","year":"2013","journal-title":"Neuropsychopharmacology."},{"key":"2026011701172674700_CIT0051","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/0004867417743343","article-title":"Electroconvulsive therapy in the continuation and maintenance treatment of depression: systematic review and meta-analyses","volume":"52","author":"Elias","year":"2018","journal-title":"Aust N Z J Psychiatry."},{"key":"2026011701172674700_CIT0052","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/104012371402600407","article-title":"Relapse prevention after index electroconvulsive therapy in treatment-resistant depression","volume":"26","author":"Youssef","year":"2014","journal-title":"Ann Clin Psychiatry."},{"key":"2026011701172674700_CIT0053","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1192\/bjo.2019.37","article-title":"Lithium for suicide and readmission prevention after electroconvulsive therapy for unipolar depression: population-based register study","volume":"5","author":"Brus","year":"2019","journal-title":"BJPsych Open."},{"key":"2026011701172674700_CIT0054","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/YCT.0000000000000547","article-title":"Efficacy of continuation\/maintenance electroconvulsive therapy in the treatment of patients with mood disorders: a retrospective analysis","volume":"35","author":"Hausmann","year":"2019","journal-title":"J ECT."},{"key":"2026011701172674700_CIT0055","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1176\/appi.ajp.2016.16010118","article-title":"A novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE study","volume":"173","author":"Kellner","year":"2016","journal-title":"Am J Psychiatry."},{"key":"2026011701172674700_CIT0056","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1590\/0004-282X20160130","article-title":"The maintenance of modified electroconvulsive therapy combined with risperidone is better than risperidone alone in preventing relapse of schizophrenia and improving cognitive function","volume":"74","author":"Yang","year":"2016","journal-title":"Arq Neuropsiquiatr."},{"key":"2026011701172674700_CIT0057","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/pcn.12859","article-title":"Shared preventive factors associated with relapse after a response to electroconvulsive therapy in four major psychiatric disorders","volume":"73","author":"Omori","year":"2019","journal-title":"Psychiatry Clin Neurosci."},{"key":"2026011701172674700_CIT0058","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/NDT.S74303","article-title":"Factors associated with the risk of relapse in schizophrenic patients after a response to electroconvulsive therapy: a retrospective study","volume":"11","author":"Shibasaki","year":"2015","journal-title":"Neuropsychiatr Dis Treat."}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/1\/sbae169\/59600350\/sbae169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/1\/sbae169\/59600350\/sbae169.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T06:17:43Z","timestamp":1768630663000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/doi\/10.1093\/schbul\/sbae169\/7811506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,10,4]]},"published-print":{"date-parts":[[2026,1,16]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbae169","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2024,10,4]]},"article-number":"sbae169"}}